Galmed Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
CEOAllen Baharaff
CEOAllen Baharaff
Employees24
Employees24
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2000
Founded2000
Employees24
Employees24
GLMD Key Statistics
Market cap8.39M
Market cap8.39M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume64.33K
Average volume64.33K
High today$0.36
High today$0.36
Low today$0.33
Low today$0.33
Open price$0.36
Open price$0.36
Volume56.36K
Volume56.36K
52 Week high$3.13
52 Week high$3.13
52 Week low$0.33
52 Week low$0.33
GLMD Earnings
-$0.48
-$0.32
-$0.16
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market